ES-015.129

N/A

Report date: 2024/11/29 15:12:22

Base Information

Drug NameES-015.129
Drug Alias NameES-015.129
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionAnti-NK cell lectin-like receptor subfamily C member 1
TargetsNK cell lectin-like receptor subfamily C member 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesElpiscience Biopharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesElpiscience Biopharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A